Status:
COMPLETED
Depot-medroxy Progesterone Acetate Injectable Contraceptives in Lactating Women 1st Week Versus 6 Week Postpartum Initiation
Lead Sponsor:
Assiut University
Conditions:
Complications of DMPA Injectable Contraceptives
Eligibility:
FEMALE
20-40 years
Phase:
NA
Brief Summary
This study aims to identify the effect of using Depot-medroxy progesterone acetate injectable contraceptives on lactating women mother and infant in 1st week versus 6th week postpartum initiation. Th...
Eligibility Criteria
Inclusion
- Desire contraception for at least one year Apparently healthy participant Age 20- 40 years old Term delivery Birth weight \>2.5 kg multipara Intend to breastfeed at time of hospital discharge Those delivered normally or by caesarean section Ready to follow and need immediate contraception
Exclusion
- Maternal health problems (DM, HTN, cardiac disease, anaemia, or any other obvious problem) Any maternal complications during labour Preterm delivery IUGR
Key Trial Info
Start Date :
January 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2023
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06100783
Start Date
January 1 2021
End Date
October 1 2023
Last Update
October 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boshra Hussien Ahmed
Asyut, Egypt, 71111